Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by courageouspipon Mar 10, 2021 10:19am
134 Views
Post# 32762023

CBD beverages

CBD beveragesSponsored post As people continue to look for new and innovative ways to take cannabis, other companies found out ways. Want to know more? Better read this.

  According to recent news, the U.S. market for plant-based functional beverages and other products are potentially blooming. It appears that other companies have decades of experience in developing, branding, and manufacturing iconic brands that resonate with people on a global scale.
 
  It seem that these other companies are into a comprehensive health and wellness industry, and could potentially offer one of the  unique and diverse portfolios of plant-based beverage and wellness products within both the CBD and the fulvic and humic mineral categories, with access to global, multi-channel distribution networks of traditional and adult use. Check disclaimer on profile and landing page. 

<< Previous
Bullboard Posts
Next >>